Appointment of a Broker
Faron Pharmaceuticals Oy ("Faron" or the "Company") Appointment of a Broker Company announcement, 29 March 2021 at 9.00 AM (EET) TURKU – FINLAND – Faron Pharmaceuticals Oy (First North: FARON, AIM: FARN), the clinical stage biopharmaceutical company, is pleased to announce the appointment of Peel Hunt LLP as the Company's sole Broker with effect from today. For more information please contact: Faron Pharmaceuticals Oy Dr Markku Jalkanen, Chief Executive Officer investor.relations@faron.com Peel Hunt LLP, Broker Dr Christopher Golden D: +44 (0)